← Open Payments lookup

MICHAEL HASSMAN: Open Payments

NPI 1922002765 · BERLIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,712 in 112 payments from 29 companies in 2025. Trend: 2023 $1,539 · 2024 $2,931 · 2025 $1,712

Food & beverage: $1,712
CompanyPaymentsAmount
Madrigal Pharmaceuticals9$254
Lilly USA, LLC15$188
Amgen Inc.14$139
Kowa Pharmaceuticals America, Inc.7$106
Alkermes, Inc.5$89
Janssen Biotech, Inc.5$88
ABBVIE INC.5$84
Lundbeck LLC4$74
PFIZER INC.8$72
Otsuka America Pharmaceutical, Inc.4$69

Products named: REZDIFFRA, REXULTI, MOUNJARO, ZORYVE, VIVITROL, TREMFYA, OTEZLA, OMVOH.

Industry payments across NJ — which companies pay providers there.